Product

ibalizumab-uiyk

Aliases

Trogarzo

Name

TROGARZO

INN Name

ibalizumab

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

HIV-1 infection

Clinical trial

A Phase 3 Study of the Safety of Trogarzo® Administered as an Undiluted "IV Push" Over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo® Experienced Patients and Healthy HIV-uninfected Volunteers

Status: Completed, Estimated PCD: 2022-10-17

Document

DailyMed Label: TROGARZO

Organization

Theratechnologies Inc.